Insmed (INSM) revenue breakdown

Healthcare · Biotechnology · Market cap $19.6B

By region, US is the largest at 75% of fiscal 2025 revenue; International grew fastest, 38% a year over 2 years.

Revenue by region

Fiscal years, as Insmed reports them in its 10-K filings; fiscal 2025 total $606M.

Regions202020212022202320242025Share
US$158M$160M$186M$224M$255M$453M 75%
International———$81M$109M$153M 25%
Japan—$16M$57M——— —
Europe and rest of world$7M$13M$3M——— —
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for INSM.
Open INSM in Investingly

Questions

Where does Insmed make its money?

In fiscal 2025, by region: US $453M, International $153M.

From Insmed's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.